UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
(Exact Name of Registrant as Specified in Charter)
| (State or another jurisdiction of incorporation) | (Commission File Number) | (IRS
Employer Identification No.) |
(Address of principal executive offices) (Zip Code)
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act: None
| Title of each class | Trading Symbol(s) | Name
of each exchange on which registered | ||
| N/A | N/A | N/A |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.
On November 5, 2026, the Board of Directors (the “Board”) approved via unanimous written consent an amendment to the Company’s Articles of Incorporation to increase the total shares of Common Stock the Company is authorized to issue from five hundred million (500,000,000) to one billion (1,000,000,000), with a par value of $0.001 per share (the “Authorized Stock Increase”), and on November 18, 2026, modified that consent to increase the authorized common stock to 20 billion (20,000,000,000). We recommended the shareholders of the Series X Preferred shares approve the Authorized Stock Increase. On November 18, 2026, shareholders holding 50.95% of Company’s voting stock, voting on as-converted basis (“Consenting Shareholders”) took this action by written consent to approve the Authorized Stock Increase.
The Board of Directors has approved this action and is taking all steps necessary to implement the change. The Company will file an information statement as soon as practical informing the shareholders of the change. The Company currently has approximately 66 million shares outstanding and around 26 million shares in the float. It also is required to reserve certain shares for the potential issuance underlying its convertible debt and other commitments. It currently has over 900 million shares, 91% of its authorized shares held in this reserve. There is no transaction or event under consideration that management believes would utilize the new level of authorized shares.
Item 8.01 Other Events.
The Company continues discussions with a number of acquisition candidates and the restructuring of its Bridge notes and Series A Preferred shares. The change in the number of authorized shares of its common stock was not related to any particular transaction or event.
Item 9.01 Financial Statements and Exhibits
| Exhibit No. | Description | |
| 104 | Cover Page Interactive Data File (formatted as Inline XBRL) |
1
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Dated: November 20, 2026 | MITESCO, INC. | |
| By: | /s/ Mack Leath | |
| Mack Leath | ||
| Chairman and CEO | ||
2